Role of steroids in a case of leptospirosis and dengue coinfection with acute respiratory distress syndrome

Authors

  • Ankita Raheja Department of Internal Medicine, H. B. T. Medical College and Dr. R. N. Cooper Municipal General Hospital, Mumbai, Maharashtra, India
  • Rayyan Sunasra Department of Internal Medicine, H. B. T. Medical College and Dr. R. N. Cooper Municipal General Hospital, Mumbai, Maharashtra, India
  • Neelam Redkar Department of Internal Medicine, H. B. T. Medical College and Dr. R. N. Cooper Municipal General Hospital, Mumbai, Maharashtra, India
  • Anuj Tiwari Department of Internal Medicine, H. B. T. Medical College and Dr. R. N. Cooper Municipal General Hospital, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20263653

Keywords:

Leptospirosis, Dengue, Coinfection, ARDS, Steroids

Abstract

Coinfection with leptospirosis and dengue complicated by acute respiratory distress syndrome (ARDS) is rare and potentially fatal. While steroids are generally contraindicated in dengue and their role in leptospirosis remains uncertain, management becomes challenging. This case highlights a situation where steroid therapy was beneficial. We describe a case of a 17-year-old male presenting with fever with chills, joint pain, abdominal pain and vomiting, hemoptysis and subsequent respiratory distress, diagnosed with concurrent leptospirosis and dengue. Despite the uncertain role of steroids in such a case of co-infections, methylprednisolone (MPS) was administered due to severe ARDS, yielding positive outcomes. This case underscores the complexity of managing coinfections and prompts reconsideration of treatment protocols. Literature review reveals conflicting evidence on steroid use in complicated cases as this one. The positive outcomes of administering steroids in this case highlight the need for further research to refine therapeutic approaches in managing complex coinfections. This case urges robust randomized controlled trials assessing corticosteroid efficacy in severe dengue shock syndrome and leptospirosis, given their potential to significantly improve patient outcomes.

References

Sikdar R, Gupta B, Chakraborty D, Chakraborti R, Chowdhury A, Mondal S, et al. A clinico-epidemiological study on leptospirosis in West Bengal: a neglected cause of acute febrile illness. Paripex Indian J Res. 2022;11(10):42-5.

Centers for Disease Control and Prevention. Dengue. In: Yellow Book. 2024. Available at: https://www. cdc.gov/yellow-book/hcp/travel-associated-infectio ns-diseases/dengue.html. Accessed on 15 May 2026.

Shenoy VV, Nagar VS, Chowdhury AA, Bhalgat PS, Juvale NI. Pulmonary leptospirosis: an excellent response to bolus methylprednisolone. Postgrad Med J. 2006;82(971):602-6.

Premaratna R, Jayasinghe KG, Liyanaarachchi EW, Weerasinghe OM, Pathmeswaran A, de Silva HJ. Effect of a single dose of methylprednisolone as rescue medication for patients who develop hypotensive dengue shock syndrome during the febrile phase: a retrospective observational study. Int J Infect Dis. 2011;15(6):e433-4.

Bandara SMR, Herath HMMTB. Effectiveness of corticosteroids in the treatment of dengue: a systematic review. Heliyon. 2018;4(9):e00816.

Rajapakse S, Rodrigo C, Maduranga S, Rajapakse AC. Corticosteroids in the treatment of dengue shock syndrome. Infect Drug Resist. 2014;7:137-43.

Panpanich R, Sornchai P, Kanjanaratanakorn K. Corticosteroids for treating dengue shock syndrome. Cochrane Database Syst Rev. 2006;(3):CD003488.

Downloads

Published

2026-09-30

How to Cite

Raheja, A., Sunasra, R., Redkar, N., & Tiwari, A. (2026). Role of steroids in a case of leptospirosis and dengue coinfection with acute respiratory distress syndrome. International Journal Of Community Medicine And Public Health, 13(10), 6090–6092. https://doi.org/10.18203/2394-6040.ijcmph20263653

Issue

Section

Case Reports